Department of Sports Medicine, China Medical University, Taichung 406040, Taiwan.
Department of Nutrition, China Medical University, Taichung 406040, Taiwan.
Am J Chin Med. 2023;51(8):2175-2193. doi: 10.1142/S0192415X23500933. Epub 2023 Nov 4.
Andrographolide (AND) is a bioactive component of the herb and a well-known anti-inflammatory agent. Atherosclerosis is a chronic inflammatory disease of the vasculature, and oxidized LDL (oxLDL) is thought to contribute heavily to atherosclerosis-associated inflammation. The aim of this study was to investigate whether AND mitigates oxLDL-mediated foam cell formation and diet-induced atherosclerosis (in mice fed a high-fat, high-cholesterol, high-cholic acid [HFCCD] diet) and the underlying mechanisms involved. AND attenuated LPS/oxLDL-mediated foam cell formation, IL-1[Formula: see text] mRNA and protein (p37) expression, NLR family pyrin domain containing 3 (NLRP3) mRNA and protein expression, caspase-1 (p20) protein expression, and IL-1[Formula: see text] release in BMDMs. Treatment with oxLDL significantly induced protein and mRNA expression of CD36, lectin-like oxLDL receptor-1 (LOX-1), and scavenger receptor type A (SR-A), whereas pretreatment with AND significantly inhibited protein and mRNA expression of SR-A only. Treatment with oxLDL significantly induced ROS generation and Dil-oxLDL uptake; however, pretreatment with AND alleviated oxLDL-induced ROS generation and Dil-oxLDL uptake. HFCCD feeding significantly increased aortic lipid accumulation, ICAM-1 expression, and IL-1[Formula: see text] mRNA expression, as well as blood levels of glutamic pyruvic transaminase (GPT), total cholesterol, and LDL-C. AND co-administration mitigated aortic lipid accumulation, the protein expression of ICAM-1, mRNA expression of IL-1[Formula: see text] and ICAM-1, and blood levels of GPT. These results suggest that the working mechanisms by which AND mitigates atherosclerosis involve the inhibition of foam cell formation and NLRP3 inflammasome-dependent vascular inflammation as evidenced by decreased SR-A expression and IL-1[Formula: see text] release, respectively.
穿心莲内酯(AND)是草药的一种生物活性成分,也是一种众所周知的抗炎剂。动脉粥样硬化是一种慢性血管炎症疾病,氧化型 LDL(oxLDL)被认为是动脉粥样硬化相关炎症的主要贡献者。本研究旨在探讨 AND 是否可以减轻 oxLDL 介导的泡沫细胞形成和高脂、高胆固醇、高胆酸(HFCCD)饮食诱导的动脉粥样硬化(喂食 HFCCD 饮食的小鼠),以及涉及的潜在机制。AND 减弱了 LPS/oxLDL 介导的泡沫细胞形成、IL-1β mRNA 和蛋白(p37)表达、NLR 家族pyrin 结构域包含 3(NLRP3)mRNA 和蛋白表达、半胱天冬酶-1(p20)蛋白表达和 BMDMs 中的 IL-1β 释放。oxLDL 处理显著诱导了 CD36、凝集素样 oxLDL 受体-1(LOX-1)和清道夫受体 A(SR-A)的蛋白和 mRNA 表达,而 AND 的预处理仅显著抑制了 SR-A 的蛋白和 mRNA 表达。oxLDL 处理显著诱导 ROS 生成和 Dil-oxLDL 摄取;然而,AND 的预处理减轻了 oxLDL 诱导的 ROS 生成和 Dil-oxLDL 摄取。HFCCD 喂养显著增加了主动脉脂质积累、ICAM-1 表达和 IL-1β mRNA 表达,以及血液中谷氨酸丙酮酸转氨酶(GPT)、总胆固醇和 LDL-C 的水平。AND 共同给药减轻了主动脉脂质积累、ICAM-1 蛋白表达、IL-1β 和 ICAM-1 的 mRNA 表达以及血液中 GPT 的水平。这些结果表明,AND 减轻动脉粥样硬化的作用机制涉及抑制泡沫细胞形成和 NLRP3 炎性体依赖性血管炎症,这分别表现为 SR-A 表达降低和 IL-1β 释放减少。